Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price traded up 100% on Thursday . The stock traded as high as C$0.03 and last traded at C$0.03. 603,000 shares traded hands during mid-day trading, an increase of 812% from the average session volume of 66,118 shares. The stock had previously closed at C$0.02.
Quest PharmaTech Price Performance
The firm has a 50 day moving average of C$0.02 and a 200-day moving average of C$0.03. The company has a current ratio of 0.54, a quick ratio of 0.52 and a debt-to-equity ratio of 4.49. The company has a market cap of C$3.38 million, a P/E ratio of -1.00 and a beta of 0.10.
Quest PharmaTech (CVE:QPT – Get Free Report) last issued its earnings results on Friday, June 28th. The company reported C($0.01) earnings per share for the quarter.
Quest PharmaTech Company Profile
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
See Also
- Five stocks we like better than Quest PharmaTech
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- What is a SEC Filing?
- Why Dell Can Continue Winning in AI and Beyond
- NYSE Stocks Give Investors a Variety of Quality Options
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
